Citation only
via OpenAlex
Updates on the Epidemiology of Age-Related Macular Degeneration
Jost Bruno Jonas, Chui Ming Gemmy Cheung, Songhomitra Panda‐Jonas
Asia-Pacific Journal of Ophthalmology · 2017 · ▲ 267 citations
Abstract
This meta-analysis reports on current estimates of the prevalence of age-related macular degeneration (AMD) based on a review of recent meta-analyses and literature research. Within an age of 45-85 years, global prevalences of any AMD, early AMD, and late AMD were 8.7% [95% credible interval (CrI), 4.3‒17.4], 8.0% (95% CrI, 4.0‒15.5), and 0.4% (95% CrI, 0.2-0.8). Early AMD was more common in individuals of European ancestry (11.2%) than in Asians (6.8%), whereas prevalence of late AMD did not differ significantly. AMD of any type was less common in individuals of African ancestry. The number of individuals with AMD was estimated to be 196 million (95% CrI, 140‒261) in 2020 and 288 million (95% CrI, 205‒399) in 2040. The worldwide number of persons blind (presenting visual acuity < 3/60) or with moderate to severe vision impairment (MSVI; presenting visual acuity < 6/18 to 3/60 inclusive) due to macular disease in 2010 was 2.1 million [95% uncertainty interval (UI), 1.9‒2.7] individuals out of 32.4 million individuals blind and 6.0 million (95% UI, 5.2‒8.1) persons out of 191 million people with MSVI. Age-standardized prevalence of macular diseases as cause of blindness in adults aged 50+ years worldwide decreased from 0.2% (95% UI, 0.2‒0.2) in 1990 to 0.1% (95% UI, 0.1‒0.2) in 2010; as cause for MSVI, it remained mostly unchanged (1990: 0.4%; 95% UI, 0.3‒0.5; 2010: 0.4%; 95% UI, 0.4‒0.6), with no significant sex difference. In 2015, AMD was the fourth most common cause of blindness globally (in approximately 5.8% of blind individuals) and third most common cause for MSVI (3.9%). These data show the globally increasing importance of AMD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.22608/apo.2017251
- Canonical
- link ↗
- Fetched
- 2026-10-19 MST
Cite this
APA
Jonas, J.B., Cheung, C.M.G., & Panda‐Jonas, S. (2017). Updates on the Epidemiology of Age-Related Macular Degeneration. <em>Asia-Pacific Journal of Ophthalmology</em>. https://doi.org/10.22608/apo.2017251
Vancouver
Jonas JB, Cheung CMG, Panda‐Jonas S. Updates on the Epidemiology of Age-Related Macular Degeneration. Asia-Pacific Journal of Ophthalmology. 2017. doi:10.22608/apo.2017251.
BibTeX
@article{jost2017Update,
title = {Updates on the Epidemiology of Age-Related Macular Degeneration},
author = {Jost Bruno Jonas and Chui Ming Gemmy Cheung and Songhomitra Panda‐Jonas},
journal = {Asia-Pacific Journal of Ophthalmology},
year = {2017},
doi = {10.22608/apo.2017251},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The Lancet Global Health 2014
Open access · CC-BY
Global prevalence of age-related macular degeneration
Ophthalmology 2017
Open access · CC-BY
Prevalence of Age-Related Macular Degeneration in Europe
JAMA 2004
Citation only
Age-Related Macular Degeneration Is the Leading Cause of Blindness . . .
British Journal of Ophthalmology 2012
Open access · CC-BY
The estimated prevalence and incidence of late stage age related macular degeneration in the UK
Archives of Ophthalmology 2004
Open access · OA
Prevalence of Age-Related Macular Degeneration in the United States
IRCCS San Raffaele 2011
Open access · US-GOV